ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHOFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHR24

Genomically rewritten and tailored humanized mouse models for various organ disorders

Active
Institution
NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY
Principal investigator
Jef D Boeke
Funding
$845K
Duration
2025–2029
Open portfolio

Moonbase score

Still being scored

Abstract

Summary This proposal leverages Big DNA technology to produce mouse models of a variety of human diseases. The underlying hypothesis tested in our earlier work and continued in this proposal is that changes in human non- coding DNA that underlie human disease susceptibility will translate into appropriate disease phenotypes in the mouse when the entire human genic region of interest is inserted into a predefined location in the mouse genome. We refer to such animals as GREAT-GEMMs (Genomically Rewritten and Tailored Genetically engineered moused models). Furthermore, GREAT-GEMMs will serve as a resource for testing therapeutic interventions against human disease. These animals will be uniquely useful for cutting edge therapies like gene therapies, CRISPR based therapies and allele specific oligonucleotide (ASO) therapies which depend on exact human DNA sequences as targets. Our work is based on our recently developed ability to synthesize and precisely edit 50-300+ kilobase DNA constructs, and then to precisely delivery them to mouse embryonic stem cells (mESCs) and subsequently produce mouse models for human disease.

Research team

  • Jef D BoekePI
  • Shane LiddelowPI

LOADING MOONBASE SCORE

R24OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHSpecial Emphasis Panel[ZRG1 BTC-Y (55)]therapiesmousemouse modelsasopreciselyoligonucleotidehuman diseasedna

Questions for NEW YORK UNIVERSITY SCHOOL OF MEDICINE

Answered by the team behind this research.

No questions yet. Sign in to ask the first one

Related grants

Same researchers, same institution, same topic, scored first.